EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Use of protracted CPAP as supportive treatment for COVID-19 pneumonitis and associated outcomes: a national cohort study

Kathryn A Puxty, Michael Blayney, Callum Kaye, Joanne McPeake, Neil Stewart, Martin Paton, Ros Hall, Lorraine Donaldson, Nazir Lone

British Journal of Anaesthesia · 2023

DOI: 10.1016/j.bja.2023.05.012 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift British Journal of Anaesthesia, 2023. Verfasst von Kathryn A Puxty und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, NHS Greater Glasgow and Clyde, Glasgow Royal Infirmary, Glasgow, UK; School of Medicine, Dentistry and Nursing, Universi…. Hauptthemen laut MEDLINE: Continuous Positive Airway Pressure, COVID-19, Pneumonia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Cambridge.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Continuous positive airway pressure (CPAP) has been increasingly deployed to manage patients with COVID-19 and acute respiratory failure, often for protracted periods. However, concerns about protracted CPAP have been raised. This study aimed to examine the use of CPAP for patients with COVID-19 and the outcomes after protracted use. METHODS: This was a national cohort study of all adults admitted to Scottish critical care units with COVID-19 from March 1, 2020 to December 25, 2021 who received CPAP. Protracted CPAP was defined as ≥ 5 continuous days of CPAP. Outcomes included CPAP failure rate (institution of invasive mechanical ventilation [IMV] or death), mortality, and outcomes after institution of IMV. Multivariable logistic regression was performed to assess the impact of protracted CPAP on mortality after IMV. RESULTS: A total of 1961 patients with COVID-19 received CPAP for COVID-19 pneumonitis, with 733 patients (37.4%) receiving protracted CPAP. CPAP failure occurred in 891 (45.4%): 544 patients (27.7%) received IMV and 347 patients (17.7%) died in critical care without IMV. Hospital mortality rate was 41.3% for the population. For patients who subsequently commenced IMV, hospital mortality was 58.7% for the standard duration CPAP group and 73.9% for the protracted duration CPAP group (P=0.003); however, there was no statistical difference in hospital mortality after adjustment for confounders (odds ratio 1.4, 95% confidence interval 0.84-2.33, P=0.195). CONCLUSIONS: Protracted CPAP was used frequently for managing patients with COVID-19. Whilst it was not associated with worse outcomes for those patients who subsequently required IMV, this might be due to residual confounding and differences in processes of care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Continuous Positive Airway PressureCOVID-19PneumoniaAdultHumansCohort StudiesRespiration, ArtificialNoninvasive Ventilation

Stichwörter der Autor:innen

ARDSCOVID-19CPAPcontinuous positive airway pressurenoninvasive ventilationpneumonitis

Autor:innen und Institutionen

  • Department of Critical Care, NHS Greater Glasgow and Clyde, Glasgow Royal Infirmary, Glasgow, UK; School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK. Electronic address: kathryn.puxty@glasgow.…
  • Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Department of Critical Care, NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, UK.
  • Healthcare Improvement Scotland (Improvement Hub), Glasgow, UK; The Institute of Healthcare Improvement Studies, University of Cambridge, Cambridge, UK.
  • Department of Critical Care, NHS Forth Valley, Forth Valley Royal Hospital, Larbert, UK.
  • Public Health Scotland, UK.

Förderung

  • University of Cambridge

Zitieren

APA

Puxty, K. A., Blayney, M., Kaye, C., McPeake, J., Stewart, N., Paton, M., Hall, R., Donaldson, L., & Lone, N. (2023). Use of protracted CPAP as supportive treatment for COVID-19 pneumonitis and associated outcomes: a national cohort study. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2023.05.012

Vancouver

Puxty KA, Blayney M, Kaye C, McPeake J, Stewart N, Paton M, et al. Use of protracted CPAP as supportive treatment for COVID-19 pneumonitis and associated outcomes: a national cohort study. British Journal of Anaesthesia. 2023. doi:10.1016/j.bja.2023.05.012

BibTeX
@article{Puxty2023,
  author = {Puxty, Kathryn A and Blayney, Michael and Kaye, Callum and McPeake, Joanne and Stewart, Neil and Paton, Martin and Hall, Ros and Donaldson, Lorraine and Lone, Nazir},
  title = {Use of protracted CPAP as supportive treatment for COVID-19 pneumonitis and associated outcomes: a national cohort study},
  journal = {British Journal of Anaesthesia},
  year = {2023},
  doi = {10.1016/j.bja.2023.05.012}
}
Kostenlos starten →